For too long, Africa’s skincare industry has been dictated by foreign brands, outdated manufacturing processes, and ...

Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...

Scrubbing the ubiquitous chemicals isocyanate and xylene from the planet would mean a whole lot less eczema, says a US ...

Spots can also look very different depending on your skin tone. Some pink, red, or brown spots are more obvious on fair to ...

Atopic eczema is the most common form of the disease among New Zealanders. The skin condition causes dry, itchy, inflamed skin, affecting approximately one in three people at some point in their lives ...

Corvus Pharmaceuticals suffered lately, especially after it announced in December 2024 its early AD data. Check out why I ...

Corvus Pharmaceuticals has faced volatility due to mixed clinical data and given the current valuation and market ...

Dupilumab treatment of atopic dermatitis resulted in long-term skin improvements linked to changes in skin’s the molecular composition.

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

Medically reviewed by William Truswell, MD Atopic dermatitis (the most common form of eczema) causes dry, itchy skin, often ...

Paris and Tarrytown, NY, March 28, 2025. The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic ...

At this week’s American Chemical Society Spring meeting, Galderma SA reported the discovery of novel, oral and selective macrocyclic inhibitors of protein kinase C θ (PKCθ) for the potential treatment ...